At what enterprise value was GROUPE RESONANCE IMAGERIE acquired in 2022?

During the acquisition of GROUPE RESONANCE IMAGERIE by ANDERA PARTNERS in 2022, the transaction's Enterprise Value is estimated to be in the range of 100M - 350M EUR.

What was the EV/EBITDA of GROUPE RESONANCE IMAGERIE when it was acquired by ANDERA PARTNERS?

The estimated EV/EBITDA multiple for GROUPE RESONANCE IMAGERIE is in the range of 15x - 25x.

What was the revenue of GROUPE RESONANCE IMAGERIE at the time of the deal?

The revenue of GROUPE RESONANCE IMAGERIE at the time of the deal is estimated to be in the range of 25M - 50M EUR.

What was the EBITDA of GROUPE RESONANCE IMAGERIE during the acquisition?

GROUPE RESONANCE IMAGERIE's EBITDA is estimated to be in the range of 5M - 25M EUR.

How is the data for the GROUPE RESONANCE IMAGERIE acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the GROUPE RESONANCE IMAGERIE deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.anderapartners.com/fr/andera-midcap-participe-au-financement-du-groupe-resonance-imagerie/

← DATABASE

Home Database Healthcare & PharmaGROUPE RESONANCE IMAGERIE

07/2022

GROUPE RESONANCE IMAGERIE acquired by ANDERA PARTNERS

FRANCE Health Providers / Outpatient Care / Radiology EV 100M - 350M EUR

Context

R�sonance Imagerie, a prominent French medical imaging group, has secured a major financing package from Andera MidCap, Ardian Private Debt, and Five Arrows Debt Partners. Established in 2011, the group currently operates a network of 15 centers across Paris, �le-de-France, and the Centre-Val-de-Loire region, managing 23 high-tech units including MRIs and scanners.

GROUPE RESONANCE IMAGERIE, which reported an EBITDA margin of in 2021, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (15.9x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Groupe Résonance Imagerie (founded in 2011) is a leading independent outpatient radiology and medical imaging network in France. The group operates a specialized clinical model combining a high volume of conventional radiology with advanced cross-sectional heavy imaging expertise. Its core value proposition focuses on providing tier-one diagnostic excellence through cutting-edge modalities (MRI, CT scans, mammography) alongside streamlined technical and administrative operational management.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2021

2020

Other operations with GROUPE RESONANCE IMAGERIE

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
10/2025	GROUPE RESONANCE IMAGERIE	CIMEP	FRANCE	Radiology

REFERENCES

Valuation range: EV 100M - 350M EUR

Revenue range: 25M - 50M EUR

EBITDA range: 5M - 25M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of GROUPE RESONANCE IMAGERIE by ANDERA PARTNERS are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Press release: view release

Target: groupe resonance imagerie

Acquirer: andera partners